The company's patent-protected technology platform, TissueCypher, analyzes whole slide digital images with multiplexed fluorescence, providing greater information and accuracy than traditional subjective tissue diagnostics. Cernostics offers high complexity clinical reference laboratory equipment that specializes in the high-dimensional analysis of tissue biopsies, providing valuable information to clinicians not available through other means. Their spatial biology and AI-driven image analytics device provides valuable insight to pharma clients on the pathophysiology of the disease, biomarker discovery and validation, and clinical trial support. Cernostics takes a tissue systems biology approach to anatomic pathology, delivering next-generation cancer diagnostics and prognostics.